Icosavax Analysis
| ICVXDelisted Stock | USD 9.02 0.12 1.31% |
Icosavax is overvalued with Real Value of 7.25 and Hype Value of 9.02. The main objective of Icosavax delisted stock analysis is to determine its intrinsic value, which is an estimate of what Icosavax is worth, separate from its market price. There are two main types of Icosavax's stock analysis: fundamental analysis and technical analysis.
The Icosavax stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Icosavax is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Icosavax Stock trading window is adjusted to America/New York timezone.
Icosavax |
Icosavax Stock Analysis Notes
About 88.0% of the company shares are owned by institutional investors. The book value of Icosavax was currently reported as 4.64. The company recorded a loss per share of 2.2. Icosavax had not issued any dividends in recent years. Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company was incorporated in 2017 and is headquartered in Seattle, Washington. Icosavax operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people. To learn more about Icosavax call Adam Simpson at 206 737 0085 or check out https://icosavax.com.Icosavax Investment Alerts
| Icosavax is not yet fully synchronised with the market data | |
| Icosavax has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (96.71 M) with loss before overhead, payroll, taxes, and interest of (30.97 M). | |
| Icosavax currently holds about 242.8 M in cash with (71.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.09. | |
| Over 88.0% of the company shares are owned by institutional investors |
Icosavax Upcoming and Recent Events
Earnings reports are used by Icosavax to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Icosavax Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 769.04 M.Icosavax Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Icosavax insiders, such as employees or executives, is commonly permitted as long as it does not rely on Icosavax's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Icosavax insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Icosavax Outstanding Bonds
Icosavax issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Icosavax uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Icosavax bonds can be classified according to their maturity, which is the date when Icosavax has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ICICI 4 18 MAR 26 Corp BondUS45112EAG44 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| US451102CC97 Corp BondUS451102CC97 | View | |
| Icahn Enterprises 525 Corp BondUS451102BZ91 | View | |
| Icahn Enterprises 625 Corp BondUS451102BT32 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| ICICI 4 18 MAR 26 Corp BondUS45112FAJ57 | View |
Icosavax Predictive Daily Indicators
Icosavax intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Icosavax stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Icosavax Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Icosavax prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Icosavax shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Icosavax. By using and applying Icosavax Stock analysis, traders can create a robust methodology for identifying Icosavax entry and exit points for their positions.
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company was incorporated in 2017 and is headquartered in Seattle, Washington. Icosavax operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Icosavax to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Icosavax Stock
If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |